Discontinued — last reported Q1 '26
Business Segments · Foreign currency translation adjustments, net
U.S. Pharmaceutical — Foreign currency translation adjustments, net
Over 2 years (FY 2022 to FY 2025), U.S. Pharmaceutical — Foreign currency translation adjustments, net shows an upward trend with a -100.0% CAGR.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026Aug 6, 2025
Rolls up toFX & Other Adjustments
How to read this metric
An increase in negative adjustments suggests unfavorable currency movements, while positive adjustments indicate favorable currency impacts on reported earnings.
Detailed definition
Represents the net impact of foreign currency exchange rate fluctuations on the financial results of the U.S. Pharmaceut...
Peer comparison
Common in multinational corporations with cross-border supply chains or international subsidiaries.
Metric ID:
mck_segment_u_s_pharmaceutical_foreign_currency_translation_adjustments_netHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.00M | -$16.00M | -$12.00M | -$19.00M | -$33.00M | -$39.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -328.6% | +25.0% | -58.3% | -73.7% | -18.2% | +100.0% | — | — | — | — | — | — | — | — |
| YoY Change | — | — | — | — | -571.4% | -143.8% | +100.0% | +100.0% | — | — | — | — | — | — | — |
Range-$39.00M – $7.00M
CAGR-100.0%
Avg YoY Growth-128.8%
Median YoY Growth-21.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's u.s. pharmaceutical — foreign currency translation adjustments, net?
- McKesson (MCK) reported u.s. pharmaceutical — foreign currency translation adjustments, net of $0.00 in Q2 2025.
- What is the long-term trend for McKesson's u.s. pharmaceutical — foreign currency translation adjustments, net?
- Over 2 years (2022 to 2025), McKesson's u.s. pharmaceutical — foreign currency translation adjustments, net has grown at a -100.0% compound annual growth rate (CAGR), from -$40.00M to $0.00.
- What does u.s. pharmaceutical — foreign currency translation adjustments, net mean?
- The net gain or loss resulting from changes in foreign currency exchange rates affecting segment financial reporting.